{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:42:49Z","timestamp":1777531369458,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.ijantimicag.2004.02.018","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T02:54:22Z","timestamp":1085799262000},"page":"606-612","source":"Crossref","is-referenced-by-count":13,"title":["Reduction in the bactericidal activity of selected cathelicidin peptides by bovine calf serum or exogenous endotoxin"],"prefix":"10.1016","volume":"23","author":[{"given":"Karen H","family":"Bartlett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Paul B","family":"McCray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter S","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB1","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1128\/AAC.45.10.2838-2844.2001","article-title":"Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis","volume":"45","author":"Saiman","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB2","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1128\/IAI.68.5.2748-2755.2000","article-title":"Bactericidal activity of mammalian cathelicidin-derived peptides","volume":"68","author":"Travis","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1165\/ajrcmb.20.5.3572","article-title":"Activity of abundant antimicrobials of the human airway","volume":"20","author":"Travis","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(95)01050-O","article-title":"Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain","volume":"374","author":"Zanetti","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0014-5793(94)80395-1","article-title":"Identification and characterization of a primary antibacterial domain CAP18, a lipopolysaccharide binding protein from rabbit leukocytes","volume":"339","author":"Tossi","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/0-306-46831-X_17","article-title":"Structure and biology of cathelicidins","volume":"479","author":"Zanetti","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB7","first-page":"317","article-title":"Structure and functions of endotoxin-binding peptides derived from CAP18","volume":"392","author":"Hirata","year":"1995","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB8","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1128\/IAI.62.4.1421-1426.1994","article-title":"Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity","volume":"62","author":"Hirata","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB9","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1128\/AAC.42.12.3269","article-title":"Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model","volume":"42","author":"Sawa","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.164.2.549","article-title":"Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein","volume":"164","author":"Scott","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4049\/jimmunol.152.1.231","article-title":"A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity","volume":"152","author":"Larrick","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB12","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1128\/IAI.66.5.1861-1868.1998","article-title":"Protective effects of a human 19-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia","volume":"66","author":"Kirikae","year":"1998","journal-title":"Infect. Immun"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-5793(95)01285-3","article-title":"cDNA sequences of three sheep myeloid cathelicidins","volume":"376","author":"Bagella","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.45.1.331-334.2001","article-title":"The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection","volume":"45","author":"Brogden","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB15","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1128\/AAC.45.11.3256-3261.2001","article-title":"Congeners of SMAP29 kill ovine pathogens and induce ultrastructure damage in bacterial cells","volume":"45","author":"Kalfa","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/protein\/15.3.225","article-title":"Impact of single-residue mutations on the structure and function of ovispirin\/novispirin antimicrobial peptides","volume":"15","author":"Sawai","year":"2002","journal-title":"Protein Eng"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB17","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1128\/AAC.46.6.1837-1844.2002","article-title":"Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns","volume":"46","author":"Steinstraesser","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB18","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1046\/j.0014-2956.2002.02751.x","article-title":"SMAP-29 has two LPS-binding sites and a central hinge","volume":"269","author":"Tack","year":"2002","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0300-483X(00)00287-0","article-title":"Inhalation toxicology models of endotoxin- and bioaerosol-induced inflammation","volume":"152","author":"Thorne","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB20","first-page":"169","article-title":"Designer assays for antimicrobial peptides","volume":"78","author":"Steinberg","year":"1997","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ijantimicag.2004.02.018_BIB21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0014-5793(99)01600-2","article-title":"SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes","volume":"463","author":"Skerlavaj","year":"1999","journal-title":"FEBS Lett"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T15:21:58Z","timestamp":1682695318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857904000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0924857904000974"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.02.018","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}